Can a Woman Taking Suboxone or Methadone Live in a Recovery Residence?
Yes. A woman who is appropriately prescribed Suboxone, another form of buprenorphine, or methadone can live in a recovery residence that is equipped to support medications for opioid use disorder.
That should be an uncomplicated answer. Unfortunately, medication stigma has a long history of taking a clear medical question and turning it into a philosophical debate in the hallway.
At Awaken Recovery Foundation, prescribed medication for opioid use disorder is not treated as a failure of recovery. It is healthcare.
What These Medications Do
Buprenorphine and methadone are FDA-approved medications used to treat opioid use disorder. They can reduce cravings and withdrawal, improve treatment retention and lower the risk of returning to illicit opioid use. Naltrexone is another approved medication option.
A resident’s decision to begin, continue, adjust or discontinue medication belongs with the resident and her qualified healthcare provider. Recovery housing should not practice medicine by house vote.
What Safe Medication Support Looks Like
Medication-affirming does not mean medication-chaotic. Recovery residences still need clear, consistent safety practices. Depending on the medication and the individual plan, these may include:
Keeping medications in original, properly labeled containers.
Following secure storage requirements.
Taking medication only as prescribed.
Coordinating transportation to a physician, pharmacy or opioid treatment program.
Using releases of information when the resident agrees that coordination is helpful.
Addressing impairment, diversion or safety concerns through fair written policies.
The standard should be the same basic standard used for other prescribed medications: support appropriate use, protect safety and respond to actual behavior rather than assumptions.
Methadone Has Additional Logistics
Methadone for opioid use disorder is generally dispensed through a certified opioid treatment program. Early in treatment, a resident may need frequent trips to the program. Take-home schedules vary based on federal rules, program policies and the resident’s clinical circumstances.
That makes transportation more than a convenience. A residence can say it accepts methadone, but if a resident has no realistic way to reach the dosing program, the welcome mat is doing more work than the program.
ARF’s transportation support can help residents maintain medication, treatment, medical and recovery appointments, subject to program scheduling and availability.
What About Suboxone?
Suboxone is a brand name for a medication containing buprenorphine and naloxone. Buprenorphine may be prescribed by an authorized clinician and filled through a pharmacy, depending on the specific medication and plan.
As with any controlled medication, storage, adherence and communication matter. But the mere presence of a prescription is not evidence that someone is “not really sober.” Recovery is measured by health, stability, behavior, purpose and freedom from harmful substance use—not by whether a person can win an argument about pharmacology at a meeting.
Maryland Funding Rules and Medication Access
The publicly posted Maryland RecoveryNet provider manual states that an MDRN-approved recovery residence may not deny services because a participant is receiving medication-assisted treatment. The manual also addresses consequences for providers that deny access based on MAT participation.
Funding and program requirements can change, so current details should always be confirmed with the State Care Coordinator and Maryland Behavioral Health Administration. The larger principle, however, is clear: medication access should not be blocked by stigma.
Questions a Resident or Referral Partner Should Ask
Before admission, ask the residence:
Does the program accept residents prescribed buprenorphine or methadone?
How are medications stored?
Can the residence assist with transportation to dosing or medication appointments?
What documentation is needed at admission?
How are medication concerns handled?
Does the residence require tapering as a condition of admission or continued stay?
A trustworthy answer will be specific, respectful and grounded in written policy. Be cautious of vague statements such as “we are open-minded, depending on the medication.” Recovery housing should not turn healthcare into a surprise quiz after move-in.
The ARF Approach
Awaken Recovery Foundation is MOUD-affirming. We welcome women who are appropriately prescribed medications for opioid use disorder and who otherwise meet program criteria. We coordinate with treatment providers when authorized, support safe medication practices and work to remove practical barriers such as transportation.
We also recognize that medication is one part of recovery. Residents still benefit from community, accountability, employment, nutrition, peer support, healthy routines and a stable place to live. Medication can support the foundation. A life still has to be built on it.
The Referral Takeaway
A woman should not have to choose between evidence-based medication and safe recovery housing. The right question is not, “Is she taking Suboxone or methadone?” The better questions are, “Is the medication prescribed? Is she medically stable? Can the residence support the plan safely? Is she ready to participate in the community?”
For medication-related referral questions or current availability, contact ARF at 410-762-9977 or info@awakenrecovery.org.
About Awaken Recovery Foundation
Awaken Recovery Foundation (ARF) provides MCORR-certified, MOUD-affirming recovery housing and practical recovery supports for adult women on Maryland’s Eastern Shore. Services include structured housing, peer support, transportation, employment and education assistance, wellness activities and connection to community-based care.
READY TO DISCUSS A REFERRAL? Contact Awaken Recovery Foundation at 410-762-9977 or info@awakenrecovery.org to ask about fit, current availability and next steps. |
Sources and Editorial Note
Editorial note: This article is educational and is not medical, legal or funding advice. Program availability, eligibility and public funding rules can change. Confirm current requirements with ARF and the responsible Maryland agency before relying on them for a placement or authorization.
MDRN source note: Maryland’s publicly posted provider manual is dated 2022. This draft summarizes that published guidance but should be checked against current State Care Coordination and Maryland RecoveryNet procedures before posting.
Comments